type 2C
active at physiological Mg2+: stimulation by
unsaturated fatty acids. FEBS Letters, 437, 229-
232 (1998).
4. Cheng, A., et al., Dephosphorylation of Human
Cyclin-dependent Kinases by Protein
Schwede, F. et al., Pharmacol. Ther., 87(2-3),
199-226 (2000).
6. Wu, X. et al., J. Lipid Res., 37(6), 1198-12066
(1996).
7. Milara, J. et al., Thorax, 67(3), 229-237 (2012).
31) Ji, R-R, et al., Neuron (2002) 36:57-68.
32) Zhu, D.Y., et al., J. Neuroscience (2003) 23:223-229.
33) Liu, S., et al., J. Neuroscience (2003) 23:in press.
34) Hafezparast, M., et al., Science
L-selectin is present in human
plasma at high levels and retains functional activity. J. Cell Biol. 119: 229-238.
13. Mengelers, H.J.J., T. Maikoe, B. Hooibrink, T.W.Kuypers, J. Kreukniet, J.W.J. Lammers
338, 783; Hayashi, T., et al. 1998. Diabetes 47, 1369; Corton, J.M., et al.
1995. Eur. J. Biochem. 229, 558.
AICA-Riboside, 5´-Phosphate
A 5´-phosphorylated analog of AICA-Riboside (Cat. No.
123040)
and validation of commercial
kits for biomarker quantification in drug development. Bioanalysis, 7, 229–242.
Lee, J. W. (2009). Method validation and application of protein biomarkers: Basic simi-
larities
y
6 β-Actin A1978 60 ACTB M NP_001092.1 y y y
7 β-Actin A2228 60 ACTB M NP_001092.1 y y y
8 a-Actinin A5044 87 ACTN1 M NP_001093.1 y y n/d
555 PARP P7605 142 PARP1 P NP_001609.2 y n/d n/d
11 β1 and β2-
y
6 β-Actin A1978 60 ACTB M NP_001092.1 y y y
7 β-Actin A2228 60 ACTB M NP_001092.1 y y y
8 a-Actinin A5044 87 ACTN1 M NP_001093.1 y y n/d
555 PARP P7605 142 PARP1 P NP_001609.2 y n/d n/d
11 β1 and β2-
y
6 β-Actin A1978 60 ACTB M NP_001092.1 y y y
7 β-Actin A2228 60 ACTB M NP_001092.1 y y y
8 a-Actinin A5044 87 ACTN1 M NP_001093.1 y y n/d
555 PARP P7605 142 PARP1 P NP_001609.2 y n/d n/d
11 β1 and β2-
F.R., and Karin, M. 2004. Cancer Lett. 206, 193; Jones, W.K., et al. 2003. Cardiovasc. Toxicol. 3
229; Richmond, A. 2002. Nat. Rev. Immunol. 2, 664.
The IKK-NF-κB System: A Target for Inflammation and